title: Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).
abstract: Five patients with drug-induced agranulocytosis received 300 micrograms recombinant human granulocyte colony-stimulating factor (rh G-CSF) subcutaneously twice daily for 2-5 days. G-CSF therapy resulted in a steep increase of the neutrophil count, which was faster than that in patients with spontaneous recovery reported in the literature. In all four patients with infectious complications fever rapidly declined with the increase of granulocytes. G-CSF may be useful in the management of drug-induced agranulocytosis.
authors.affiliation: First Department of Internal Medicine, Division of Hematology and Blood Coagulation, Vienna, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Willfort
authors.forename: C
authors.initials: C
authors.lastname: Lorber
authors.forename: S
authors.initials: S
authors.lastname: Kapiotis
authors.forename: S
authors.initials: S
authors.lastname: Sertl
authors.forename: R
authors.initials: R
authors.lastname: Hainz
authors.forename: P
authors.initials: P
authors.lastname: Kirchweger
authors.forename: U
authors.initials: U
authors.lastname: Jäger
authors.forename: P A
authors.initials: PA
authors.lastname: Kyrle
authors.forename: K
authors.initials: K
authors.lastname: Lechner
authors.forename: K
authors.initials: K
authors.lastname: Geissler
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000188:drug therapy*; D004177:Dipyrone / Q000009:adverse effects*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008713:Methimazole / Q000009:adverse effects*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole; D004177:Dipyrone